AdAlta Limited (ASX: 1AD) CEO and Managing Director, Dr Tim Oldham presented at the Investor Summit on 1 June, 2023.
The webinar presentation covers how AdAlta, as a clinical stage biotech company is developing a pipeline of next generation therapeutics to treat challenging diseases in fibrosis and oncology. It covers AdAlta’s three partnering streams:
1️⃣ out-licensing AD-214;
2️⃣ partnering the i-body platform; and
3️⃣ evaluating complimentary technologies and products.
To watch the webinar, click on the below image.